Personalized neuroscience is an emerging interdisciplinary field that intersects neuroscience and personalized medicine, aiming to decipher individual variations in brain structure, function, and connectivity to customize interventions and treatments for diverse neurological and psychiatric conditions. Unlike conventional neuroscience approaches that often generalize findings across populations, personalized neuroscience recognizes the inherent diversity in brain function and treatment responses among individuals. Leveraging cutting-edge technologies such as functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and genetics, researchers can delve deeper into the unique characteristics of each person's brain. A pivotal aspect of personalized neuroscience involves the use of biomarkers—genetic markers, neural activity patterns, and neuroimaging signatures—to characterize brain health and forecast responses to interventions. By pinpointing these biomarkers, clinicians can devise personalized treatment strategies tailored to an individual's distinct neurobiological profile. This approach holds promise across various domains, including mental health, neurodegenerative diseases, and cognitive enhancement. In psychiatry, personalized neuroscience enables optimization of medication selection and dosages based on a patient's neurobiological makeup, potentially minimizing side effects and enhancing treatment outcomes. Likewise, in neurodegenerative disorders like Alzheimer's and Parkinson's, it facilitates early detection and intervention, potentially delaying disease progression. Overall, personalized neuroscience represents a paradigm shift in understanding and addressing neurological and psychiatric conditions, paving the way for more effective, targeted interventions that improve patient outcomes and quality of life.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States